Aurobindo Pharma’s Board of Directors has approved an investment of Rs. 66 crores to acquire up to a 26% stake in Garuda Renewables…

Embassy Developments Limited announced that its Nomination and Remuneration Committee approved the grant of 9,15,265 Stock Options (SOs) and…

Aurobindo Pharma reported robust financial results for the third quarter of FY26 (Q3FY26), achieving a consolidated revenue of ₹8,646 Cr,…

Rallis India Limited announced the appointment of Mr. Ashok Sharma (DIN: 02766679) as an Additional Director, effective February 10, 2026. He…

YES BANK announced the receipt of a significant redemption amount of INR 76 Crores. This redemption stems from a single trust within the…

Embassy Developments Limited announced exceptional results for Q3 FY26 (ending December 31, 2025), highlighted by a massive ~240%…

Supriya Lifescience Ltd. announced the outcome of its Board Meeting held on February 09, 2026. The Board approved the Unaudited Financial…